The global stem cell banking market reached a value of US$ 6.8 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 10.9 Billion by 2027, exhibiting a CAGR of 8.42% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Stem cell banking is one of the most promising as well as the fastest growing segment of the next-generation stem cell therapy. It is the process of extracting, freezing and storing stem cells for potential future use. Some of the sources through which stem cells are obtained include embryo, umbilical cord, cord blood, placenta and bone marrow. These cells are used for treating a number of different diseases including diabetes, thalassemia, leukemia, sickle cell anemia and cardiac diseases. Moreover, they are also employed for generating platelets, red blood cells and white blood cells. The potential of stem cells to regenerate has led to their applications in tissue engineering, gene therapy and regenerative medicines.
www.imarcgroup.com
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
To get more information about this market,Request Sample
Global Stem Cell Banking Market Drivers:
While the average human life expectancy has increased owing to the advancements in medical science, human aging is still associated with several diseases. Thus, the elevating count of geriatric population will drive the demand for stem cell therapy in the coming years.
Regulatory authorities as well as non-governmental organizations (NGO), across both developed and emerging regions, are taking initiatives for instilling awareness amongst consumers about the therapeutic potentials of stem cells, thereby influencing the stem cell banking market growth.
Increasing fertility rates has led to a rise in the number of children across the globe. This offers lucrative opportunities for preserving the umbilical cord of infants which contains hematopoietic (blood) stem cells.
Some of the other factors which are catalyzing the growth of the market include escalating disposable incomes, increasing approval of clinical trials in stem cell research, growing prevalence of chronic diseases and technological advancements.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global stem cell banking market, along with forecasts at the global and regional level from 2022-2027. Our report has categorized the market based on product type, service type, bank type, utilization and application.
Breakup by Product Type:
www.imarcgroup.com
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
To get more information about this market, Request Sample
Adult Stem Cells
Human Embryonic Cells
IPS Cells
On the basis of product types, the market has been segmented as adult stem cells, human embryonic cells and IPS cells. Presently, adult stem cells account for the majority of the market share as they help in repairing damaged tissues via cell division. In addition to this, adult stem cells offer advantages like ease of harvesting, high acceptance in the human body and effectiveness in tissue generation.
Breakup by Service Type:
Sample Preservation and Storage
Sample Analysis
Sample Processing
Sample Collection and Transportation
Based on service types, the market has been segmented as sample preservation and storage, sample analysis, sample processing, and sample collection and transportation.
Breakup by Bank Type:
Private
Public
Based on the bank type, the market has been segregated as private and public stem cell banks. Private stem cell banks currently dominate the market, holding the largest share.
Breakup by Utilization:
Used
Unused
Based on the utilization, the market has been segregated as used and unused.
Breakup by Application:
Personalized Banking Applications
Research Applications
Clinical Applications
On the basis of application, the market has been segmented as personalized banking applications, research applications and clinical applications.
Regional Insights:
www.imarcgroup.com
To get more information on the regional analysis of this market,Request Sample
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
On a geographical front, North America enjoys the leading position in the global stem cell banking market on account of advancements in medical infrastructure and availability of federal funding for stem cell research. Other regions include Europe, Asia Pacific, Middle East and Africa, and Latin America.
Competitive Landscape:
The market is fragmented in nature with the presence various international as well as regional players. Some of the leading players operating in the market are:
CBR Systems Inc.
China Cord Blood Corporation
Cordlife
Cordvida
Cryo-Cell International, Inc.
Cryo-Save AG (A Group of Esperite)
Cryoviva India
Lifecell
Smart Cells International Ltd
Viacord
Report Coverage:
Report Features
Details
Base Year of the Analysis
2021
Historical Period
2016-2021
Forecast Period
2022-2027
Units
US$ Billion
Segment Coverage
Product Type, Service Type, Bank Type, Utilization, Application,Region
Region Covered
Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Companies Covered
CBR Systems Inc., China Cord Blood Corporation, Cordlife, Cordvida, Cryo-Cell International, Inc., Cryo-Save AG (A Group of Esperite), Cryoviva India, Lifecell, Smart Cells International Ltd and Viacord
Customization Scope
10% Free Customization
Report Price and Purchase Option
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support
10-12 Weeks
Delivery Format
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report
The global stem cell banking market was valued at US$ 6.8 Billion in 2021.
We expect the global stem cell banking market to exhibit a CAGR of 8.42% during 2022-2027.
The increasing consumer awareness towards numerous therapeutic benefits of stem cells for treating
several diseases, including diabetes, leukemia, cardiac ailments, etc., is currently driving the global stem
cell banking market.
The sudden outbreak of the COVID-19 pandemic has led to the increasing application of next-generation
stem cell therapy for managing severe symptoms of the coronavirus infection.
Based on the product type, the global stem cell banking market can be segmented into adult stem cells,
human embryonic cells, and IPS cells. Currently, adult stem cells hold the majority of the total market
share.
Based on the service type, the global stem cell banking market has been divided into sample
preservation and storage, sample analysis, sample processing, and sample collection and transportation.
Among these, sample preservation and storage currently exhibits a clear dominance in the market.
Based on the bank type, the global stem cell banking market can be categorized into private and public.
Currently, private stem cell banks account for the majority of the global market share.
Based on the utilization, the global stem cell banking market has been segregated into used and unused,
where unused currently holds the largest market share.
Based on the application, the global stem cell banking market can be bifurcated into personalized
banking applications, research applications, and clinical applications. Among these, clinical applications
currently exhibit a clear dominance in the market.
On a regional level, the market has been classified into North America, Europe, Asia Pacific, Middle East
and Africa, and Latin America, where North America currently dominates the global market.
Some of the major players in the global stem cell banking market include CBR Systems Inc., China Cord
Blood Corporation, Cordlife, Cordvida, Cryo-Cell International, Inc., Cryo-Save AG (A Group of Esperite),
Cryoviva India, Lifecell, Smart Cells International Ltd., Viacord, etc.
Need more help?
Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-713-2163
Email: sales@imarcgroup.com
Client Testimonials
IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
This site uses cookies (including third-party cookies) to record user’s preferences which help us to enhance our services. For further information review our Privacy Policy.
This site uses cookies to improve user experience.Privacy Policy.